Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China’s leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.
- 18 years ago
QualityStocks
Shengtai Pharmaceutical Inc., (OTC BB: SGTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…